Arkolith/Insider Trading/RPTX/Form 4

Zinda Michael

EVP, CHIEF SCIENTIFIC OFFICERRepare Therapeutics Inc. (RPTX) · full profile →Form 4 · filed Apr 1, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4K
Net Open-Market Flow
-$4K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2024Sell(S)410$4.66$2K72K
Mar 28, 2024Sell(S)450$4.64$2K72K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-009625) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML